Viewing Opinion | StockChase
Teva Pharmaceutical (TEVA-N) opinion on 2017-02-08

Last Price Recorded: 13.4800 on 2017-11-22

ON STOCKCHASE SINCE Dec 2000

biotechnology/pharmaceutical
DON'T BUY

Cameron Hurst
Teva Pharmaceutical was $32.380 at time of opinion
Owned : Unknown

There will be a time when this will be a hero stock for someone who bought it at the low. However, that is a tough call to make. Your odds of getting it right are low. The whole space is highly political right now.

BULLISH

All opinions for TEVA-N (234)

45 BUY
4 BUY on WEAKNESS
43 COMMENT
39 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List

All opinions for TEVA-N (234)

45 BUY
4 BUY on WEAKNESS
43 COMMENT
39 DON'T BUY
13 HOLD
2 PARTIAL BUY
26 PAST TOP PICK
8 SELL
3 STRONG BUY
44 TOP PICK
1 VAGUE
4 WAIT
2 WATCH
View All

More experts covering TEVA-N

SAVE
Add TEVA-N to Watch List
Post Comment

1 Comment

jordy

February 8th 2017 at 12:54pm

Teva has taken on a lot of debt to add generics. On the branded side it's more about legal battles to extend Copaxone's patents than the product itself. There is value in the company that will eventually be realized, but yeah, maybe now is not quite the right time to be a hero.


You must be logged in to comment.

Successfully Saved Company